Evidence for a Dopaminergic Mechanism for the Prolactin Inhibitory Effect of Atrial Natriuretic Factor
- 1 January 1988
- journal article
- research article
- Published by S. Karger AG in Neuroendocrinology
- Vol. 47 (3) , 268-271
- https://doi.org/10.1159/000124922
Abstract
Infusion of 2 nmol atrial natriuretic factor (ANF) into the third cerebroventricle of conscious, orchidectomized male rats results in a significant inhibition of prolactin (PRL) secretion. This effect is prevented by prior treatment with the dopamine receptor antagonist, domperidone. Furthermore, domperidone reverses the inhibitory effect when given after ANF infusion. The PRL-inhibiting effect is absent as well following inhibition of tyrosine hydroxylase activity. These results suggest that ANF acts centrally at least in part via an interaction with endogenous dopaminergic systems and further suggests potent neuromodulatory actions of the peptide within the hypothalamus.Keywords
This publication has 8 references indexed in Scilit:
- Hypothalamic action of atrial natriuretic factor to inhibit vasopressin secretionPeptides, 1987
- Inhibitory effect of centrally administered atrial natriuretic polypeptide on the brain dopaminergic system in ratsEuropean Journal of Pharmacology, 1986
- Evidence for a Physiological Role for Oxytocin in the Control of Prolactin Secretion*Endocrinology, 1986
- Atrial natriuretic factor inhibits dehydration- and angiotensin II-induced water intake in the conscious, unrestrained rat.Proceedings of the National Academy of Sciences, 1985
- A prolactin-inhibiting factor within the precursor for human gonadotropin-releasing hormoneNature, 1985
- Atrial natriuretic factor (ANF) binding sites in brain and related structuresPeptides, 1984
- Prolactin-Releasing Effect of a Novel Anti-Dopaminergic Drug, Domperidone, in the RatNeuroendocrinology, 1980
- Influence of Dopaminergic Agonists and Antagonists on Serum Prolactin Concentrations in the RatNeuroendocrinology, 1976